Shanthakumar Dhurka, Leiloglou Maria, Kelliher Colm, Darzi Ara, Elson Daniel S, Leff Daniel R
Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK.
The Hamlyn Centre, Imperial College London, London SW7 2AZ, UK.
Cancers (Basel). 2023 May 23;15(11):2884. doi: 10.3390/cancers15112884.
Up to 19% of patients require re-excision surgery due to positive margins in breast-conserving surgery (BCS). Intraoperative margin assessment tools (IMAs) that incorporate tissue optical measurements could help reduce re-excision rates. This review focuses on methods that use and assess spectrally resolved diffusely reflected light for breast cancer detection in the intraoperative setting. Following PROSPERO registration (CRD42022356216), an electronic search was performed. The modalities searched for were diffuse reflectance spectroscopy (DRS), multispectral imaging (MSI), hyperspectral imaging (HSI), and spatial frequency domain imaging (SFDI). The inclusion criteria encompassed studies of human in vivo or ex vivo breast tissues, which presented data on accuracy. The exclusion criteria were contrast use, frozen samples, and other imaging adjuncts. 19 studies were selected following PRISMA guidelines. Studies were divided into point-based (spectroscopy) or whole field-of-view (imaging) techniques. A fixed-or random-effects model analysis generated pooled sensitivity/specificity for the different modalities, following heterogeneity calculations using the Q statistic. Overall, imaging-based techniques had better pooled sensitivity/specificity (0.90 (CI 0.76-1.03)/0.92 (CI 0.78-1.06)) compared with probe-based techniques (0.84 (CI 0.78-0.89)/0.85 (CI 0.79-0.91)). The use of spectrally resolved diffusely reflected light is a rapid, non-contact technique that confers accuracy in discriminating between normal and malignant breast tissue, and it constitutes a potential IMA tool.
在保乳手术(BCS)中,高达19%的患者因切缘阳性而需要再次切除手术。结合组织光学测量的术中切缘评估工具(IMA)有助于降低再次切除率。本综述重点关注在术中使用和评估光谱分辨漫反射光进行乳腺癌检测的方法。在PROSPERO注册(CRD42022356216)之后,进行了电子检索。检索的模式包括漫反射光谱(DRS)、多光谱成像(MSI)、高光谱成像(HSI)和空间频域成像(SFDI)。纳入标准包括对人体体内或体外乳腺组织的研究,这些研究提供了准确性数据。排除标准为使用造影剂、冷冻样本和其他成像辅助手段。按照PRISMA指南选择了19项研究。研究分为基于点的(光谱学)或全场视(成像)技术。在使用Q统计量进行异质性计算之后,采用固定效应或随机效应模型分析得出不同模式的合并敏感性/特异性。总体而言,与基于探头的技术(0.84(CI 0.78 - 0.89)/0.85(CI 0.79 - 0.91))相比,基于成像的技术具有更好的合并敏感性/特异性(0.90(CI 0.76 - 1.03)/0.92(CI 0.78 - 1.06))。使用光谱分辨漫反射光是一种快速、非接触的技术,在区分正常和恶性乳腺组织方面具有准确性,并且它构成了一种潜在的IMA工具。